SCHEMBL25528752

SCHEMBL25528752

CN/C(=C\C=N)c1ccc2c(c1)N(C)C(=O)[C@@H](C)N(Cc1cccc(C(=O)NCC3CCN(C)CC3)c1)C2=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.42
GLS O94925 1/20 0.39
HDAC3 O15379 4/20 0.37
HDAC4 P56524 4/20 0.37
HDAC1 Q13547 4/20 0.37
HDAC7 Q8WUI4 4/20 0.37
HDAC2 Q92769 4/20 0.37
HDAC10 Q969S8 4/20 0.37
HDAC11 Q96DB2 4/20 0.37
HDAC8 Q9BY41 4/20 0.37
HDAC6 Q9UBN7 4/20 0.37
HDAC9 Q9UKV0 4/20 0.37
HDAC5 Q9UQL6 4/20 0.37
ROCK2 O75116 4/20 0.37
NAMPT P43490 1/20 0.36
BRD4 O60885 3/20 0.36
BRD2 P25440 1/20 0.36
BRD3 Q15059 1/20 0.36
BRDT Q58F21 1/20 0.36
THRB P10828 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25528344 0.90 MAP4K4 (0.36) PARP1HDAC4ROCK2NAMPTBRD4
SCHEMBL25528758 0.88 PARP1 (0.42) PARP1GLSHDAC3HDAC4HDAC1
SCHEMBL25528339 0.86 PARP1 (0.41) PARP1GLSHDAC3HDAC4HDAC1
SCHEMBL25528196 0.79 ROCK2 (0.43) PARP1GLSHDAC3HDAC4HDAC1
SCHEMBL25529693 0.79 ROCK2 (0.51) PARP1ROCK2ROCK1
SCHEMBL25528767 0.79 MAP4K4 (0.38) PARP1HDAC4NAMPTBRD4CACNA1G
SCHEMBL25528343 0.78 PARP1 (0.43) PARP1GLSHDAC3HDAC4HDAC1
SCHEMBL25528340 0.77 PARP1 (0.44) PARP1GLSROCK2MAP4K4ROCK1
SCHEMBL25528771 0.74 ROCK2 (0.42) PARP1HDAC3HDAC4HDAC1HDAC7
SCHEMBL25528337 0.74 BRD4 (0.39) ROCK2BRD4THRBCACNA1GROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023093787-A1 BENZODIAZEPINE COMPOUND AND APPLICATION THEREOF AS RHO KINASE INHIBITOR 成都奥睿药业有限公司 2023-06-01 WO disclosed